about
The ramifications of HLA-B27HLA-B27-associated reactive arthritis: pathogenetic and clinical considerationsAnkylosing spondylitis: A state of the art factual backboneCellular Expression and Crystal Structure of the Murine Cytomegalovirus Major Histocompatibility Complex Class I-like Glycoprotein, m153From HLA-B27 to spondyloarthritis: a journey through the ER.Individual characterization of stably expanded T cell clones in ankylosing spondylitis patients.IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis.Increased levels of IgG antibodies against human HSP60 in patients with spondyloarthritis.Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infectionStructural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)MHC-bound antigens and proteomics for novel target discovery.Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort.Human migration, diversity and disease association: a convergent role of established and emerging DNA markersPeptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis.Human leukocyte antigen-b27 and disease susceptibility in vojvodina, serbia.GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.Periodontal pathogens are likely to be responsible for the development of ankylosing spondylitis.Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).Contribution of functional KIR3DL1 to ankylosing spondylitis.Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo.MHC class I dimer formation by alteration of the cellular redox environment and induction of apoptosis.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action.Association of HLA-DRB1*14 with rheumatic heart disease patients from Chandigarh, North India.Formation of HLA-B27 homodimers and their relationship to assembly kinetics.Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27.[Molecular pathological diagnostics of infections in orthopedic pathology].Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides.
P2860
Q24522252-66A96E13-9DFC-403A-9ABD-E34F648B07B5Q24625587-16AA9C4D-BE1B-4AF6-8F64-DAE23B2560EBQ26782184-E2E7ECDC-7CF5-4C87-BA74-801D61954E90Q27648567-08D41B7B-B94B-4302-9ACC-52C723588D73Q27687662-08887BEF-4E89-404A-9342-1F86F74AC5A6Q33491043-4B8DA850-ACBF-4AE2-BDB2-5E4F1608A4C4Q33765701-F2B9687D-00FA-4F84-AC42-5AC36FC15364Q34592752-4EDE9913-E78E-49B4-A1BE-E169280FDC65Q34994754-01CD5741-E9BE-46BB-B99D-09C8C1F87F4FQ35133849-069C4813-F5FC-4B46-8424-B8776D6724EAQ35911151-1B539535-06B3-489D-8397-7E9DE778F6AEQ37077012-1C0427A6-E2CF-432C-8AB2-69958D150763Q37083519-8F5CBB0A-C362-4FB2-8A29-96A665E87B30Q37167616-13DBF352-7673-4768-92AB-CB0998CB0063Q37181495-D8D3C28D-4FB4-4F8B-A22E-F506B4763E1AQ38093041-DD3861D4-E520-4394-90F8-2F626CAE76ABQ38499216-138B2F40-7215-4942-91CE-3AB9D05CAF93Q38959953-F440A038-7851-4997-9903-24B6572DA856Q39021980-C6115A10-E1CB-410E-A967-BD452F191B5FQ39291937-A56CDAE0-4596-407F-844F-7EA86364CDDFQ39449645-17720C60-D666-4B92-8558-1EA9869B48B2Q40097257-347706D0-C4A7-44D6-82F6-147D71F90788Q40159351-7CB479D2-EA75-42E9-A106-97C384F798A6Q40301273-E6D4A349-9EC4-40D9-9367-661572C8AFB8Q40605908-8F2A4567-98E7-4B64-9185-0C823D581951Q41176761-40DFE72A-7218-498D-9799-B5B1DF6AE6BBQ41662793-E74EA3A8-EEAE-4A27-BFC8-2111728335B5Q42266445-AE069FE2-0746-4A7F-8365-E80F69DFE5BA
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HLA B27 in health and disease: a double-edged sword?
@ast
HLA B27 in health and disease: a double-edged sword?
@en
HLA B27 in health and disease: a double-edged sword?
@nl
type
label
HLA B27 in health and disease: a double-edged sword?
@ast
HLA B27 in health and disease: a double-edged sword?
@en
HLA B27 in health and disease: a double-edged sword?
@nl
prefLabel
HLA B27 in health and disease: a double-edged sword?
@ast
HLA B27 in health and disease: a double-edged sword?
@en
HLA B27 in health and disease: a double-edged sword?
@nl
P356
P1433
P1476
HLA B27 in health and disease: a double-edged sword?
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/41.8.857
P50
P577
2002-08-01T00:00:00Z